Article
Biomarkers in frontotemporal lobar degeneration.
Current opinion in neurology - 1 Dec 2010
Grossman Murray
Abstract excerpt
PURPOSE OF REVIEW: Recent findings assessing the utility of neuroimaging and biofluid biomarkers are reviewed that help identify patients with frontotemporal lobar degeneration (FTLD) spectrum abnormality. RECENT FINDINGS: Neuroimaging studies using T1 structural MRI and diffusion tensor imaging (DTI) distinguish between patients with FTLD and Alzheimer's disease, although the reliability of these group-level...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
